<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p104" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_104{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_104{left:808px;bottom:1132px;letter-spacing:-0.08px;}
#t3_104{left:162px;bottom:1085px;letter-spacing:0.11px;word-spacing:-0.35px;}
#t4_104{left:162px;bottom:1067px;letter-spacing:0.11px;word-spacing:0.03px;}
#t5_104{left:162px;bottom:1050px;letter-spacing:0.12px;}
#t6_104{left:221px;bottom:1050px;letter-spacing:0.11px;word-spacing:2.55px;}
#t7_104{left:730px;bottom:1050px;letter-spacing:0.11px;word-spacing:2.55px;}
#t8_104{left:162px;bottom:1032px;letter-spacing:0.11px;word-spacing:2.69px;}
#t9_104{left:162px;bottom:1015px;letter-spacing:0.12px;word-spacing:2.26px;}
#ta_104{left:162px;bottom:997px;letter-spacing:0.12px;word-spacing:3.3px;}
#tb_104{left:162px;bottom:979px;letter-spacing:0.11px;word-spacing:0.63px;}
#tc_104{left:162px;bottom:962px;letter-spacing:0.1px;word-spacing:0.05px;}
#td_104{left:162px;bottom:944px;letter-spacing:0.1px;word-spacing:0.28px;}
#te_104{left:162px;bottom:927px;letter-spacing:0.09px;word-spacing:0.02px;}
#tf_104{left:162px;bottom:909px;letter-spacing:0.11px;word-spacing:1.51px;}
#tg_104{left:346px;bottom:909px;letter-spacing:0.11px;word-spacing:1.52px;}
#th_104{left:162px;bottom:892px;letter-spacing:0.1px;word-spacing:0.03px;}
#ti_104{left:162px;bottom:874px;letter-spacing:0.14px;}
#tj_104{left:298px;bottom:874px;letter-spacing:0.12px;word-spacing:0.03px;}
#tk_104{left:141px;bottom:817px;letter-spacing:0.14px;}
#tl_104{left:162px;bottom:796px;letter-spacing:0.14px;word-spacing:0.08px;}
#tm_104{left:162px;bottom:775px;letter-spacing:0.14px;}
#tn_104{left:162px;bottom:740px;letter-spacing:0.06px;word-spacing:-0.22px;}
#to_104{left:274px;bottom:748px;letter-spacing:-0.1px;}
#tp_104{left:283px;bottom:748px;}
#tq_104{left:288px;bottom:740px;letter-spacing:0.11px;word-spacing:-0.34px;}
#tr_104{left:376px;bottom:748px;}
#ts_104{left:380px;bottom:740px;letter-spacing:0.11px;word-spacing:-0.45px;}
#tt_104{left:478px;bottom:748px;}
#tu_104{left:483px;bottom:740px;letter-spacing:0.11px;word-spacing:-0.4px;}
#tv_104{left:582px;bottom:748px;}
#tw_104{left:587px;bottom:740px;letter-spacing:0.11px;word-spacing:-0.84px;}
#tx_104{left:675px;bottom:748px;}
#ty_104{left:680px;bottom:740px;letter-spacing:0.05px;word-spacing:1.04px;}
#tz_104{left:781px;bottom:748px;letter-spacing:-0.1px;}
#t10_104{left:790px;bottom:748px;}
#t11_104{left:795px;bottom:740px;letter-spacing:0.08px;word-spacing:0.57px;}
#t12_104{left:162px;bottom:723px;letter-spacing:0.13px;}
#t13_104{left:240px;bottom:731px;}
#t14_104{left:245px;bottom:723px;letter-spacing:0.11px;word-spacing:-0.02px;}
#t15_104{left:354px;bottom:731px;letter-spacing:-0.02px;}
#t16_104{left:363px;bottom:731px;}
#t17_104{left:368px;bottom:723px;letter-spacing:0.12px;word-spacing:0.04px;}
#t18_104{left:468px;bottom:731px;letter-spacing:-0.02px;}
#t19_104{left:478px;bottom:731px;}
#t1a_104{left:162px;bottom:713px;}
#t1b_104{left:167px;bottom:706px;letter-spacing:0.11px;word-spacing:-0.49px;}
#t1c_104{left:162px;bottom:696px;}
#t1d_104{left:167px;bottom:688px;letter-spacing:0.12px;word-spacing:4.62px;}
#t1e_104{left:739px;bottom:696px;}
#t1f_104{left:743px;bottom:688px;letter-spacing:0.12px;word-spacing:4.74px;}
#t1g_104{left:162px;bottom:670px;letter-spacing:0.11px;word-spacing:0.14px;}
#t1h_104{left:779px;bottom:678px;}
#t1i_104{left:784px;bottom:670px;letter-spacing:0.14px;}
#t1j_104{left:162px;bottom:653px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1k_104{left:162px;bottom:618px;letter-spacing:0.15px;}
#t1l_104{left:243px;bottom:618px;letter-spacing:0.11px;word-spacing:0.93px;}
#t1m_104{left:162px;bottom:600px;letter-spacing:0.11px;word-spacing:0.55px;}
#t1n_104{left:162px;bottom:582px;letter-spacing:0.08px;word-spacing:-1.08px;}
#t1o_104{left:162px;bottom:565px;letter-spacing:0.1px;word-spacing:-0.28px;}
#t1p_104{left:162px;bottom:547px;letter-spacing:0.13px;word-spacing:2.7px;}
#t1q_104{left:312px;bottom:547px;letter-spacing:0.11px;word-spacing:2.54px;}
#t1r_104{left:162px;bottom:530px;letter-spacing:0.11px;word-spacing:0.04px;}
#t1s_104{left:806px;bottom:530px;letter-spacing:0.1px;}
#t1t_104{left:162px;bottom:512px;letter-spacing:0.08px;}
#t1u_104{left:196px;bottom:512px;letter-spacing:0.09px;}
#t1v_104{left:222px;bottom:512px;letter-spacing:0.09px;}
#t1w_104{left:269px;bottom:512px;letter-spacing:0.11px;word-spacing:0.53px;}
#t1x_104{left:162px;bottom:495px;letter-spacing:0.11px;word-spacing:-0.09px;}
#t1y_104{left:162px;bottom:476px;letter-spacing:0.12px;}
#t1z_104{left:210px;bottom:476px;letter-spacing:0.11px;word-spacing:1.95px;}
#t20_104{left:162px;bottom:458px;letter-spacing:0.09px;word-spacing:-1.04px;}
#t21_104{left:162px;bottom:440px;letter-spacing:0.11px;word-spacing:1.81px;}
#t22_104{left:334px;bottom:440px;letter-spacing:0.1px;}
#t23_104{left:380px;bottom:440px;letter-spacing:0.1px;word-spacing:1.79px;}
#t24_104{left:467px;bottom:440px;letter-spacing:0.09px;word-spacing:1.9px;}
#t25_104{left:521px;bottom:440px;letter-spacing:0.1px;word-spacing:1.8px;}
#t26_104{left:629px;bottom:440px;letter-spacing:0.11px;}
#t27_104{left:704px;bottom:440px;letter-spacing:0.11px;word-spacing:1.8px;}
#t28_104{left:162px;bottom:423px;letter-spacing:0.11px;word-spacing:0.44px;}
#t29_104{left:162px;bottom:405px;letter-spacing:0.11px;word-spacing:0.03px;}
#t2a_104{left:162px;bottom:388px;letter-spacing:0.12px;word-spacing:-0.88px;}
#t2b_104{left:336px;bottom:388px;letter-spacing:0.1px;word-spacing:-0.69px;}
#t2c_104{left:162px;bottom:370px;letter-spacing:0.11px;word-spacing:-0.82px;}
#t2d_104{left:162px;bottom:352px;letter-spacing:0.14px;}
#t2e_104{left:283px;bottom:352px;letter-spacing:0.11px;word-spacing:0.4px;}
#t2f_104{left:162px;bottom:335px;letter-spacing:0.12px;word-spacing:1.29px;}
#t2g_104{left:162px;bottom:317px;letter-spacing:0.11px;word-spacing:-0.05px;}
#t2h_104{left:141px;bottom:261px;letter-spacing:0.15px;}
#t2i_104{left:162px;bottom:240px;letter-spacing:0.1px;}
#t2j_104{left:162px;bottom:205px;letter-spacing:0.04px;word-spacing:0.11px;}
#t2k_104{left:261px;bottom:205px;letter-spacing:0.13px;word-spacing:0.04px;}
#t2l_104{left:402px;bottom:205px;letter-spacing:0.12px;word-spacing:-0.03px;}
#t2m_104{left:162px;bottom:187px;letter-spacing:0.11px;word-spacing:-0.08px;}
#t2n_104{left:162px;bottom:152px;letter-spacing:0.15px;}
#t2o_104{left:243px;bottom:152px;letter-spacing:0.11px;word-spacing:1.32px;}
#t2p_104{left:162px;bottom:135px;letter-spacing:0.11px;word-spacing:2.03px;}
#t2q_104{left:162px;bottom:117px;letter-spacing:0.11px;word-spacing:2.31px;}
#t2r_104{left:162px;bottom:99px;letter-spacing:0.11px;}
#t2s_104{left:162px;bottom:82px;letter-spacing:0.14px;}
#t2t_104{left:219px;bottom:82px;letter-spacing:0.11px;word-spacing:0.13px;}

.s0_104{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_104{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_104{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s3_104{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s4_104{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
.s5_104{font-size:15px;font-family:TimesNewRomanPS-ItalicMT_8n;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts104" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-ItalicMT_8n;
	src: url("fonts/TimesNewRomanPS-ItalicMT_8n.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg104Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg104" style="-webkit-user-select: none;"><object width="935" height="1210" data="104/104.svg" type="image/svg+xml" id="pdf104" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_104" class="t s0_104">Brain: Chemistry to Cognition </span><span id="t2_104" class="t s1_104">96 </span>
<span id="t3_104" class="t s0_104">different immunocompetent cells in the choroid. Capillary changes in the choroid of young and aged animals </span>
<span id="t4_104" class="t s0_104">were evaluated using TEM. </span>
<span id="t5_104" class="t s2_104">Results: </span><span id="t6_104" class="t s0_104">The control rats showed fenestrated capillaries with a mean luminal diameter </span><span id="t7_104" class="t s0_104">of 12±2.5 µm, </span>
<span id="t8_104" class="t s0_104">whereas in experimental rats, they were larger in size (mean diameter: 16.7-19.4 µm). In controls, the </span>
<span id="t9_104" class="t s0_104">endothelium and pericyte in most vessels were intact, whereas the endothelium was vacuolated and the </span>
<span id="ta_104" class="t s0_104">pericyte layer was electron-dense in aged rats. The level of proinflammatory cytokine markers in the </span>
<span id="tb_104" class="t s0_104">choroidal homogenates of aged rats was significantly higher than that of young rats. Whole-mount choroid </span>
<span id="tc_104" class="t s0_104">revealed mast cells were oriented along the capillaries. The quantity of Iba-1 positive microglia increased in </span>
<span id="td_104" class="t s0_104">older rats compared to younger rats. These findings suggest that both mast cells and microglia contribute to </span>
<span id="te_104" class="t s0_104">capillary injury. </span>
<span id="tf_104" class="t s2_104">Discussion and conclusion: </span><span id="tg_104" class="t s0_104">These findings suggest that immunocompetent cells play a role in choroidal </span>
<span id="th_104" class="t s0_104">capillary changes with ageing. </span>
<span id="ti_104" class="t s2_104">Acknowledgements: </span><span id="tj_104" class="t s0_104">Supported by funds from ICMR, New Delhi (51/4/2000-ANA/BMS, TCN). </span>
<span id="tk_104" class="t s3_104">P23: In-house natural product library screening identifies a resveratrol oligomer as </span>
<span id="tl_104" class="t s3_104">Monoamine oxidase inhibitor in brain: therapeutic implications against Parkinson's </span>
<span id="tm_104" class="t s3_104">disease </span>
<span id="tn_104" class="t s2_104">Chayan Banerjee </span>
<span id="to_104" class="t s4_104">a, </span><span id="tp_104" class="t s4_104">b </span>
<span id="tq_104" class="t s0_104">, Raju Barman </span>
<span id="tr_104" class="t s4_104">c </span>
<span id="ts_104" class="t s0_104">, Priya Darshani </span>
<span id="tt_104" class="t s4_104">c </span>
<span id="tu_104" class="t s0_104">, Meghana Pillai </span>
<span id="tv_104" class="t s4_104">a </span>
<span id="tw_104" class="t s0_104">, Sanchi Ahuja </span>
<span id="tx_104" class="t s4_104">a </span>
<span id="ty_104" class="t s0_104">,Rupsha Mondal </span>
<span id="tz_104" class="t s4_104">a, </span><span id="t10_104" class="t s4_104">b </span>
<span id="t11_104" class="t s0_104">, VS </span>
<span id="t12_104" class="t s0_104">Pragadheesh </span>
<span id="t13_104" class="t s4_104">d </span>
<span id="t14_104" class="t s0_104">, Joy Chakraborty </span>
<span id="t15_104" class="t s4_104">a, </span><span id="t16_104" class="t s4_104">b </span>
<span id="t17_104" class="t s0_104">, Deepak Kumar </span>
<span id="t18_104" class="t s4_104">b, </span><span id="t19_104" class="t s4_104">c </span>
<span id="t1a_104" class="t s4_104">a </span>
<span id="t1b_104" class="t s0_104">Cell Biology and Physiology Division, CSIR- Indian Institute of Chemical Biology, Kolkata- 700032, India; </span>
<span id="t1c_104" class="t s4_104">b </span>
<span id="t1d_104" class="t s0_104">Academy of Scientific and Innovative Research (AcSIR), Ghaziabad- 201002, India; </span>
<span id="t1e_104" class="t s4_104">c </span>
<span id="t1f_104" class="t s0_104">Organic and </span>
<span id="t1g_104" class="t s0_104">Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata- 700032, India; </span>
<span id="t1h_104" class="t s4_104">d </span>
<span id="t1i_104" class="t s0_104">CSIR- </span>
<span id="t1j_104" class="t s0_104">Central Institute of Medicinal and Aromatic Plants, Research Centre, Bengaluru, 560065, India </span>
<span id="t1k_104" class="t s2_104">Background</span><span id="t1l_104" class="t s0_104">: Due to progressive loss of dopaminergic (DAergic) neurons at substantia nigra, Parkinson’s </span>
<span id="t1m_104" class="t s0_104">disease (PD) patients experience DA shortage at striatum. As Monoamineoxidase (MAO) metabolizes DA, </span>
<span id="t1n_104" class="t s0_104">managing its activity is instrumental to preserve DA levels. Though plant-derived compounds are well-utilized </span>
<span id="t1o_104" class="t s0_104">in therapeutics, identificationof promising MAO inhibitors is still insufficient. </span>
<span id="t1p_104" class="t s2_104">Material and methods</span><span id="t1q_104" class="t s0_104">: Based on current literature, we choose 39 compounds of different classes and </span>
<span id="t1r_104" class="t s0_104">screenedfor their MAO inhibitory properties and the appropriate molecule was evaluated for preliminary </span><span id="t1s_104" class="t s5_104">in- </span>
<span id="t1t_104" class="t s5_104">vitro </span><span id="t1u_104" class="t s0_104">and </span><span id="t1v_104" class="t s5_104">in-vivo </span><span id="t1w_104" class="t s0_104">toxicity studies. Finally, therapeutic implication of the molecule was evaluated in a toxin- </span>
<span id="t1x_104" class="t s0_104">induced sporadic mouse model of PD. </span>
<span id="t1y_104" class="t s2_104">Results</span><span id="t1z_104" class="t s0_104">: CB1 (a resveratrol oligomer; Mol. formula C42H30O9) offers highest level of MAO inhibition </span>
<span id="t20_104" class="t s0_104">among all compounds and exhibits no effect on cell viability, cellular reactiveoxygen species (ROS) levels and </span>
<span id="t21_104" class="t s0_104">mitochondrial morphology </span><span id="t22_104" class="t s5_104">in-vitro</span><span id="t23_104" class="t s0_104">. Preliminary </span><span id="t24_104" class="t s5_104">in- vivo </span><span id="t25_104" class="t s0_104">toxicity study in </span><span id="t26_104" class="t s5_104">Drosophila </span><span id="t27_104" class="t s0_104">does not show any </span>
<span id="t28_104" class="t s0_104">alteration as well. The compoundcould not protect against toxin induced DAergic neuronal loss in sporadic </span>
<span id="t29_104" class="t s0_104">PD model, however, PD-associated akinesia and catalepsy are mitigated via elevated levels of striatal DA. </span>
<span id="t2a_104" class="t s2_104">Discussion and conclusions</span><span id="t2b_104" class="t s0_104">: We propose to consider CB1 as an adjuvant therapeutic agent for PD associated </span>
<span id="t2c_104" class="t s0_104">behavioral improvements or in conditions where MAO inhibition may offer therapeuticamelioration. </span>
<span id="t2d_104" class="t s2_104">Acknowledgement</span><span id="t2e_104" class="t s0_104">: The authors are thankful to the director of CSIR-IICB for providing necessary support </span>
<span id="t2f_104" class="t s0_104">and funding. RM, CB, PD and RB are recipient of research fellowships from CSIR, UGC, NIPER-K and </span>
<span id="t2g_104" class="t s0_104">CSIR (MLP-138) respectively. </span>
<span id="t2h_104" class="t s3_104">P24: p38MAPK inhibitor SB202190 regulates iron storage component ferritin inglioma </span>
<span id="t2i_104" class="t s3_104">cells </span>
<span id="t2j_104" class="t s0_104">Poonam Gupta, </span><span id="t2k_104" class="t s2_104">Chayanika Banerjee, </span><span id="t2l_104" class="t s0_104">Avijit Paul, Chinmay K. Mukhopadhyay </span>
<span id="t2m_104" class="t s0_104">Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067 </span>
<span id="t2n_104" class="t s2_104">Background</span><span id="t2o_104" class="t s0_104">: High iron availability is required for enhanced growth and proliferation for any cancer cell </span>
<span id="t2p_104" class="t s0_104">including glioma. We recently reported that endogenous phosphoinositol-3-kinaseactivity could suppress </span>
<span id="t2q_104" class="t s0_104">translation of iron storage component ferritin to avail higher iron pool for proliferation in glioma cells. </span>
<span id="t2r_104" class="t s0_104">However, role of any other kinase remains unexplored. </span>
<span id="t2s_104" class="t s2_104">Methods</span><span id="t2t_104" class="t s0_104">: Glioma cells were treated with p38MAPK inhibitor SB202190 and ferritin subunitswere detected </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
